BioAge Labs (BIOA) Income from Continuing Operations (2023 - 2026)
BioAge Labs (BIOA) posted Income from Continuing Operations of 22207000.0 for Q1 2026, down 41.33% sequentially from 15713000.0 in Q4 2025, and down 70.4% YoY from 75032829.66 in Q1 2025.
BioAge Labs (BIOA) Income from Continuing Operations (2023 - 2026) Analysis & Trends
BioAge Labs has reported Income from Continuing Operations for 4 years, with the latest figure at 22207000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 70.4% year-over-year to 22207000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 92030000.0 (up 35.26% YoY) and the FY2025 annual result came in at 125940000.0, down 56.33% from the prior year.
- Income from Continuing Operations declined to 22207000.0 in Q1 2026 per BIOA's latest filing, from 15713000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 11791000.0 in Q3 2023 and troughed at 82204000.0 in Q3 2024.
- A 4-year average of 25071818.18 and a median of 15776000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations plunged 597.18% in 2024, then jumped 65.27% in 2025.
- Over 4 years, Income from Continuing Operations stood at 15776000.0 in 2023, then slumped by 97.86% to 31215000.0 in 2024, then soared by 49.66% to 15713000.0 in 2025, then sank by 41.33% to 22207000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 22207000.0, 15713000.0, and 28553000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | BioAge Labs | 436.51 Mn | 436.51 Mn | -14.23 Mn | -25.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -157.61 Mn |
| Mar 31, 2026 | -22.21 Mn |
| Dec 31, 2025 | -15.71 Mn |
| Sep 30, 2025 | -28.55 Mn |
| Jun 30, 2025 | -25.56 Mn |
| Mar 31, 2025 | -13.03 Mn |
| Dec 31, 2024 | -31.22 Mn |
| Sep 30, 2024 | -82.20 Mn |
| Jun 30, 2024 | -15.71 Mn |
| Mar 31, 2024 | -14.03 Mn |
| Dec 31, 2023 | -15.78 Mn |
| Sep 30, 2023 | -11.79 Mn |